Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)
No Thumbnail
Authors
Dettenhofer, MarkusOndrejović, Miroslav
Slavica, Anita
Kurtanjek, Zelimir
Tapaloaga, Dana
Tapaloaga, Paul Rodian
Kapur-Pojskić, Lejla
Durmić-Pasić, Adaleta
Begović, Jelena
Nedović, Viktor
Dundar, Munis
Gartland, Kevan M. A.
Miertus, Stanislav
Article (Published version)
Metadata
Show full item recordAbstract
Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highl...ighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors' actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision.
Keywords:
Smart Specialization Strategy (RIS3) / small and medium enterprise (SME) / research and innovation (R&I) / public financing science / New and preaccession EU countries (NPA) / higher education / Central and Eastern Europe (CEE) / Biotechnology (BT)Source:
Critical Reviews in Biotechnology, 2019, 39, 1, 137-155Publisher:
- Taylor & Francis Ltd, Abingdon
Funding / projects:
- Slovak Research and Development Agency [APVV-14-0294, APVV-14-0393, APVV-15-0111, APVV-16-0088, APVV-17-0239]
- Agentura na Podporu Vyskumu a Vyvoja
DOI: 10.1080/07388551.2018.1498443
ISSN: 0738-8551
PubMed: 30372630
WoS: 000451853600009
Scopus: 2-s2.0-85052909304
Collections
Institution/Community
Institut za molekularnu genetiku i genetičko inženjerstvoTY - JOUR AU - Dettenhofer, Markus AU - Ondrejović, Miroslav AU - Slavica, Anita AU - Kurtanjek, Zelimir AU - Tapaloaga, Dana AU - Tapaloaga, Paul Rodian AU - Kapur-Pojskić, Lejla AU - Durmić-Pasić, Adaleta AU - Begović, Jelena AU - Nedović, Viktor AU - Dundar, Munis AU - Gartland, Kevan M. A. AU - Miertus, Stanislav PY - 2019 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/1241 AB - Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highlighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors' actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision. PB - Taylor & Francis Ltd, Abingdon T2 - Critical Reviews in Biotechnology T1 - Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB) EP - 155 IS - 1 SP - 137 VL - 39 DO - 10.1080/07388551.2018.1498443 ER -
@article{ author = "Dettenhofer, Markus and Ondrejović, Miroslav and Slavica, Anita and Kurtanjek, Zelimir and Tapaloaga, Dana and Tapaloaga, Paul Rodian and Kapur-Pojskić, Lejla and Durmić-Pasić, Adaleta and Begović, Jelena and Nedović, Viktor and Dundar, Munis and Gartland, Kevan M. A. and Miertus, Stanislav", year = "2019", abstract = "Innovation holds the potential for economic prosperity. Biotechnology (BT) has proved to be a viable vehicle for the development and utilization of technologies, which has brought not only advances to society, but also career opportunities to nation-states that have enabling conditions. In this review, we assess the current state of BT-related activities within selected new and preaccession EU countries (NPA) of CEE region namely Croatia, Romania, Bosnia and Herzegovina and Serbia, examining educational programs, research activity, enterprises, and the financing systems. The field of BT covers a broad area of activities, including medical, food and agriculture, aquaculture or marine, environmental, biofuels, bioinformatics, and many others. Under the European Commission (EC), member-states are to set their Research and Innovation Strategies for Smart Specialization (RIS3), to identify priorities or strengths in order to develop knowledge intensive economies. As the four countries highlighted in this review are in the early stages of implementing RIS3 or have not yet fully formulated, it presents an opportunity to learn from the successes and failures of those that have already received major structural funds from the EC. A critical point will be the ability of the public and private sectors' actors to align, in the implementation of RIS3 as new investment instruments emerge, and to concentrate efforts on a few select target goals, rather than distribute funding widely without respect to a long-term vision.", publisher = "Taylor & Francis Ltd, Abingdon", journal = "Critical Reviews in Biotechnology", title = "Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)", pages = "155-137", number = "1", volume = "39", doi = "10.1080/07388551.2018.1498443" }
Dettenhofer, M., Ondrejović, M., Slavica, A., Kurtanjek, Z., Tapaloaga, D., Tapaloaga, P. R., Kapur-Pojskić, L., Durmić-Pasić, A., Begović, J., Nedović, V., Dundar, M., Gartland, K. M. A.,& Miertus, S.. (2019). Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB). in Critical Reviews in Biotechnology Taylor & Francis Ltd, Abingdon., 39(1), 137-155. https://doi.org/10.1080/07388551.2018.1498443
Dettenhofer M, Ondrejović M, Slavica A, Kurtanjek Z, Tapaloaga D, Tapaloaga PR, Kapur-Pojskić L, Durmić-Pasić A, Begović J, Nedović V, Dundar M, Gartland KMA, Miertus S. Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB). in Critical Reviews in Biotechnology. 2019;39(1):137-155. doi:10.1080/07388551.2018.1498443 .
Dettenhofer, Markus, Ondrejović, Miroslav, Slavica, Anita, Kurtanjek, Zelimir, Tapaloaga, Dana, Tapaloaga, Paul Rodian, Kapur-Pojskić, Lejla, Durmić-Pasić, Adaleta, Begović, Jelena, Nedović, Viktor, Dundar, Munis, Gartland, Kevan M. A., Miertus, Stanislav, "Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB)" in Critical Reviews in Biotechnology, 39, no. 1 (2019):137-155, https://doi.org/10.1080/07388551.2018.1498443 . .